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Peft Atrial Ablation Versus Biatrial Ablation
or Persistent and Permanent Atrial Fibrillation
Prospective and Randomized Study
eonardo Calò, MD, FESC,* Filippo Lamberti, MD,† Maria Luisa Loricchio, MD,‡
rmenegildo De Ruvo, MD,* Furio Colivicchi, MD, FESC,§ Leopoldo Bianconi, MD,§
laudio Pandozi, MD, FESC,§ Massimo Santini, MD, FESC, FACC§
ome, Italy
OBJECTIVES The aim of this study was to compare—in patients with persistent and permanent atrial
fibrillation (AF)—the efficacy and safety of left atrial ablation with that of a biatrial
approach.
BACKGROUND Left atrium-based catheter ablation of AF, although very effective in the paroxysmal form of
the arrhythmia, has an insufficient efficacy in patients with persistent and permanent AF.
METHODS Eighty highly symptomatic patients (age, 58.6  8.9 years) with persistent (n  43) and
permanent AF (n 37), refractory to antiarrhythmic drugs, were randomized to two different
ablation approaches guided by electroanatomical mapping. A procedure including circum-
ferential pulmonary vein, mitral isthmus, and cavotricuspid isthmus ablation was performed
in 41 cases (left atrial ablation group). In the remaining 39 patients (biatrial ablation group),
the aforementioned approach was integrated by the following lesions in the right atrium:
intercaval posterior line, intercaval septal line, and electrical disconnection of the superior
vena cava.
RESULTS During follow-up (mean duration 14 5 months), AF recurred in 39% of patients in the left
atrial ablation group and in 15% of patients in the biatrial ablation group (p  0.022).
Multivariable Cox regression analysis showed that ablation technique was an independent
predictor of AF recurrence during follow-up.
CONCLUSIONS In patients with persistent and permanent AF, circumferential pulmonary vein ablation,
combined with linear lesions in the right atrium, is feasible, safe, and has a significantly higher
success rate than left atrial and cavotricuspid ablation alone. (J Am Coll Cardiol 2006;47:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.02.0472504–12) © 2006 by the American College of Cardiology Foundation
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Secent clinical investigations have shown that the electrical
solation of the pulmonary vein (PV) tissue may reduce atrial
brillation (AF) recurrences in up to 70% of patients with
aroxysmal AF (1). However, the efficacy of this ablation
echnique in patients with prolonged forms of AF is rather
ow (1). Consequently, several other ablation approaches,
haracterized by a substrate modification other than PV
blation, have been proposed in persistent or permanent AF
2–8). Overall, such alternative ablation procedures seem to
e more effective than PV isolation, even if their success
ates appear extremely variable (2–8).
Experimental (9–19) and clinical (20–24) studies showed
hat the right atrium can be involved in the AF initiation
nd maintenance, and we recently found that a specific right
trial linear concept in combination with antiarrhythmic
rugs was quite effective in treating drug-refractory AF (25).
urthermore, areas localized in both atria characterized by
ragmented electrograms or rapid electrical activity (7,26)
ave shown to be critical in the AF persistence. Thus,
aking into account these observations, we have hypothe-
From the *Division of Cardiology, Policlinico Casilino, ASL RM B, Rome, Italy;
Division of Cardiology, Sant’Eugenio Hospital, Rome, Italy; ‡Department of
ardiac Diseases, Sandro Pertini Hospital, Rome, Italy; and the §Department of
ardiac Diseases, San Filippo Neri Hospital, Rome, Italy.o
Manuscript received November 22, 2005; revised manuscript received January 20,
005, accepted February 7, 2006.ized that in prolonged forms of AF biatrial ablation could
e more effective than left atrial ablation alone. Accordingly,
im of this prospective and randomized study was to
ompare—in patients with persistent and permanent AF—
he efficacy and safety of left atrial ablation, combined with
avotricuspid isthmus ablation, with that of a biatrial ap-
roach, including left atrial catheter ablation and linear
esions in the right atrium. When possible, the predeter-
ined lesions were performed along sites of fractionated
lectrograms or rapid electrical activity.
ETHODS
tudy subjects. Eighty consecutive patients (28 women,
8.6  8.9 years) undergoing radiofrequency catheter abla-
ion for symptomatic, persistent (43 patients) or permanent
F (37 patients), were enrolled in the study. Inclusion
riteria were: 1) AF resistant to more than three attempts of
harmacological and/or electrical cardioversion; or 2) recur-
ent, persistent AF despite prophylaxis with at least three
ifferent antiarrhythmic drugs (class I and/or III). Atrial
brillation was defined as persistent when lasting more than
even days and as permanent AF when resistant to cardio-
ersion or relapsing within 24 h (27). The clinical charac-
eristics of the patients are shown in Table 1.
tudy protocol. The study was planned as a prospective,
pen, and randomized trial with parallel groups. The study
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June 20, 2006:2504–12 Left and Right Atrial Ablation in Atrial Fibrillationrotocol was approved by the ethics committee of our
nstitution. Eligible patients were assigned to one of the two
tudy arms immediately before the ablation procedure ac-
ording to a computer-generated randomization list. All
atients were informed of the investigational nature of the
rocedure and provided written informed consent before
eing included in the study and randomized.
According to randomization, 41 patients underwent cir-
umferential ablation plus mitral and cavotricuspid isthmus
blation (left atrial ablation group), while 39 patients
nderwent biatrial ablation. Sixty-seven patients had struc-
ural heart disease. The clinical characteristics of the pa-
ients in the two groups were similar (Table 1).
To enhance the likelihood of maintaining sinus
hythm, oral amiodarone was administered in all the
atients who had no contraindication to the drug. In this
ast case, alternative drugs were used (sotalol, flecainide,
ropafenone). All patients were thus on antiarrhythmic
rugs during the procedure (Table 1). Forty-two patients
20 persistent and 22 permanent) were on amiodarone when
he ablation has been performed. The antiarrhythmic ther-
py was discontinued six months after the procedure. After
his period, the decision to continue antiarrhythmic medi-
ations was based on AF occurrence or the presence of
requent and/or repetitive atrial ectopic beats. After the
blation, patients were treated with low-molecular-weight
eparin for four to six days and placed on anticoagulant
herapy. After six months, in the absence of AF recurrences,
nticoagulant treatments were discontinued, unless other
ajor risk factors were present. Follow-up consisted of
utpatient visits, echocardiography, and Holter monitoring
erformed one and three months after the ablation proce-
ure and, subsequently, every three months, or in case of
ccurrence of any clinical symptom. All patients were
nstructed to regularly assess their pulse and to confirm on
lectrocardiogram (ECG) any suspected recurrence of ar-
hythmia. Transesophageal echocardiography was per-
ormed three months after ablation to assess potential PV
arrowing.
The primary end point of the study was the time to the
rst recurrence of AF during follow-up. Atrial fibrillation
ecurrence was defined as any electrocardiographically con-
rmed episode of AF lasting30 s. After an episode of AF,
ormal study participation ended, and the patient was
ithdrawn from any further analysis. Time to AF recur-
ence was computed as the number of days between the
blation procedure and the electrocardiographic confirma-
Abbreviations and Acronyms
AF  atrial fibrillation
AFCL  atrial fibrillation cycle length
CI  confidence interval
CS  coronary sinus
PV  pulmonary veinion of the arrhythmia. As the episodes of AF occurring vithin the first few weeks after ablation are usually tran-
ient, any event taking place within the first six weeks of
ollow-up was excluded from the analysis (7). Actually, 9 of
he 41 (22%) patients in the left atrial group and 5 of the 39
13%) in the biatrial group had AF recurrence during the
rst six weeks of follow-up.
apping and ablation procedure. Two quadripolar stan-
ard catheters were placed in the coronary sinus (CS) and
n the right ventricle. After transseptal catheterization,
eparin was titrated to maintain an activated clotting
ime of 250 to 300 s. A special deflectable 8-mm tip
atheter (NAVISTAR, Biosense-Webster, Diamond Bar,
alifornia) was used for mapping and ablation. Real-time
hree-dimensional left atrial and right atrial maps were
econstructed using a nonfluoroscopic mapping system
CARTO, Biosense-Webster). The mapping procedure was
erformed during AF. Maps were acquired to assess ampli-
ude of local atrial electrograms. Areas of fractionated atrial
lectrograms or rapid atrial activity were tagged on the
hree-dimensional maps. When possible, the predetermined
esions were performed both in left and right atrium along
hese sites, tagged as multiple fractionated atrial electro-
rams or rapid activity (7,26). Fractionated atrial electro-
rams were defined as atrial electrograms composed of
wo deflections or more, and/or perturbation of the
aseline with continuous deflection of a prolonged acti-
ation complex over a 10-s recording period (26). Rapid
ctivity was defined as atrial electrograms with a very short
ycle length (120 ms) averaged over a 10-s recording
eriod (26).
Radiofrequency power was titrated to achieve a temper-
ture of 50°C to 60°C for 20 to 60 s (maximum power of
0 W) for each single lesion to reduce the local peak-to-
able 1. Clinical Characteristics of Patients Who Underwent
iatrial Ablation and Left Atrial Ablation
Biatrial
Ablation
(n  39)
Left Atrial
Ablation
(n  41)
p
Value
ge, yrs 57.9  8.9 59.2  9.1 0.6
ender, M/F, n 26/13 26/15 0.8
uration of atrial fibrillation, yrs 8  3 7  4 0.3
ersistent atrial fibrillation, n 19 24 0.4
ermanent atrial fibrillation, n 20 17 0.4
tructural heart disease, n 33 34 0.9
Hypertension, n 16 18 1.0
Coronary artery disease, n 8 9 0.9
Idiopathic DC, n 5 4 0.9
Valvular disease, n 4 3 0.9
eft atrial diameter, mm 50.8  5 51.1  5 0.5
V ejection fraction, % 50.2  7.8 51.2  7.4 0.6
AD during the procedure
Amiodarone 20 22 0.9
Sotalol 9 8 0.9
Class 1C 10 11 0.9
ata are shown as mean  SD in case of continuous variables; in case of categorical
ariables, the number of patients (n) is reported.AAD  antiarrhythmic drugs; DC  dilated cardiomyopathy; LV  left
entricular.
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Left and Right Atrial Ablation in Atrial Fibrillation June 20, 2006:2504–12eak bipolar electrogram amplitude by 80% or 0.1 mV.
hen there was a 80% decrease in the local electrogram
mplitude or when energy had already been applied for 60 s,
he catheter was moved to the next site. Left atrial ablation
onsisted of: 1) circumferential lines performed1 cm from
he PV ostia; and 2) connection from the inferior portion of
eft inferior encircling lesion to the mitral annulus (mitral
sthmus). After completion of the encircling lesions, addi-
ional applications of radiofrequency energy were delivered
ithin the circles at sites where the local electrogram
mplitude was 0.1 mV (maximum power output to 50 W
nd target temperature to 50°C). The end point of the
rocedure was the completion of the proposed circular
nd linear lesions, whereas neither definite isolation of
he PV nor complete block along the lines was a required
rerequisite of the procedure. Cavotricuspid isthmus abla-
ion was then performed to achieve a bidirectional conduc-
ion block.
In the patients who underwent biatrial ablation, the
ollowing lesions, other than cavotricuspid isthmus ablation,
ere added in the right atrium: 1) a posterior intercaval line;
) a septal line from the septal portion of the superior vena
ava to the fossa ovalis, proceeding to the CS ostium where
circumferential line around the ostium was performed,
articularly burning the posteroseptal area just behind the
stium, and then the line terminates in the inferior vena
ava; and 3) the electrical disconnection of the superior vena
ava from the right atrium (25). The isolation of the
uperior vena cava was performed in all patients during sinus
hythm (target, 50°C with a power limit of 40 W). To avoid
hrenic nerve injury, just before radiofrequency delivery,
igh amplitude stimulation was performed during discon-
ection of superior vena cava. The proximal His bundle was
agged on the CARTO map and the mid-portion of the
eptal line and the portion around CS was performed—if
ossible—in sinus rhythm, to avoid atrioventricular node
amage.
When AF was terminated during ablation, we did not
e-induce AF, and the procedure was continued, until all the
redetermined linear lesions were completed. In all patients
e have determined the atrial fibrillation cycle length
AFCL) within CS: 1) before ablation; 2) after left atrial
blation; and 3) after right atrial ablation in those patients
andomized to this arm of the study. If AF terminated
uring ablation, the AFCL was determined before termi-
ation. The measurements were performed as published by
aïssaguerre et al. (28).
tatistical analysis. Means ( SD) were calculated for
ontinuous variables, while frequencies were measured for
ategorical variables. Distributions of continuous variables
ere determined by the Kolmogorov-Smirnov test, and all
ere found to be non-normal. Group differences for con-
inuous data were then examined by the Mann-Whitney
wo-sample test. In case of categorical variables, group
ifferences were examined by chi-square or Fisher exact test
s appropriate. In particular, the Fisher exact tests was ppplied in case of an expected frequency of 5. A value of
 0.05 was considered significant.
The primary analysis of outcomes was by intention to
reat. The recurrence of AF in the two treatment groups was
ested with the odds ratio of the two-binomial proportion
nalysis. Sample size calculation was based on an expected
0% per year recurrence rate of AF in the biatrial ablation
rm and on an expected 50% per year recurrence rate in the
eft atrial ablation arm. Consequently, with an alpha level of
.05 and a test power of 0.80, the resulting sample size was
0 patients in each treatment group.
The cumulative risk of recurrence of AF within each
roup was estimated by means of the Kaplan-Meier
ethod. The survival curves of the two different treatment
roups were then formally compared by use of the log-rank
est. The Cox proportional hazards regression method was
sed to determine the relationship of clinical characteristics
o the recurrence of AF during follow-up. The following
ariables, determined from the baseline evaluation, were
onsidered potential predictors of recurrence of AF: age,
ender, left atrial dimensions, structural heart disease, left
entricular ejection fraction, treatment group, and presence
f permanent AF before the ablation procedure. Besides,
he continuation of antiarrhythmic medications after six
onths from the ablation procedure was also entered in the
ox model as a time-dependent covariate. Variables were
hen analyzed in a stepwise fashion to develop Cox models
f the study end point. Data analysis was performed using
he SPSS statistical software package (version 12.0, SPSS
nc., Chicago, Illinois).
ESULTS
rocedural data. All patients were in AF at the beginning
f ablation, and all of them completed the planned inter-
entional procedure. In the left atrial ablation group, the
ean procedure and fluoroscopy duration was 164  25
in and 31  10 min, respectively, while the mean total
uration of radiofrequency energy applications was 44  12
in. In the biatrial ablation group, the mean procedure and
uoroscopy duration was 228  32 min (p  0.001 vs. left
trial ablation group) and 41  14 min (p  0.0005 vs. left
trial ablation group), respectively, while the mean total
uration of radiofrequency energy applications was 63  16
in (p  0.001 vs. left atrial ablation group). The mean
ower and temperature during ablation was similar in the
eft atrial ablation group and in the biatrial ablation group
36  14 W and 37  15 W, respectively; 51  6°C and
9  7°C, respectively).
Atrial fibrillation terminated during ablation in 43 cases
53%), 10 of 41 patients (24%) in the left atrial ablation
roup and 33 of 39 patients (85%) in the biatrial ablation
roup (p  0.0001). Of these 43 patients, AF converted to
inus rhythm in 35 cases, to typical atrial flutter in 3
atients, and to atypical atrial flutter in 5 cases.
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June 20, 2006:2504–12 Left and Right Atrial Ablation in Atrial FibrillationIn the biatrial ablation group, the AF terminated in the
eft atrium in 9 cases and in the right atrium in the
emaining 24 cases. A gradual organization of atrial elec-
rograms and a progressive increase of atrial cycle length
receded sinus rhythm restoration (Fig. 1). A significant
ncrease in AFCL was found after left atrial ablation (172
1 ms to 199  12 ms; p  0.001). The AFCL prolonged
urther in the patient who underwent right atrial ablation
199  12 ms to 235  19 ms; p  0.001). This increase
as significantly greater in patients with sinus rhythm
estoration during ablation compared with those with per-
istence of AF after ablation (174  9 ms to 221  14 ms
s. 170  12 ms to 247  15 ms), representing an increase
f 77  19 versus 48  11 (p  0.001). In the 37 patients
47%) in whom the ablation procedure was not associated
ith sinus rhythm restoration, AF was terminated by
butilide (15 patients) or by electrical cardioversion (22
atients).
The post-ablation voltage maps revealed the absence of
iscrete electrical activity (voltage 0.1 mV) at all sites
igure 1. Intended line designs: anteroposterior of a mesh graph of the ele
ots represent ablation lines. The following lesions were performed in the r
ena cava. (B) The posterior intercaval line. (C) The septal line that begin
inus ostium where a circumferential line was performed, and terminates i
round the left and right pulmonary veins. In addition, a linear lesion connectin
eft anterior oblique.nside the lesions and just around ablation lines in all
atients of both groups (Fig. 2). The electrical disconnec-
ion of the superior vena cava was obtained in all patients
ho underwent biatrial approach.
The number of radiofrequency applications required to
solate the superior vena cava was 2.5  1.2 (range 2 to 12).
he mean total radiofrequency energy application was 79
3 s (range 38 to 212 s).
linical outcome. Patients were followed for 14  5
onths, and the follow-up period was not different in the
wo study groups (13  6 months in the left atrial ablation
roup and 15  5 months in the biatrial ablation group).
trial fibrillation recurred in 16 of 41 patients (39%) in the
eft atrial ablation group after a mean time of 3.0  1.5
onths and in 6 of 39 patients (15%) in the biatrial ablation
roup after a mean time of 3.9  2.3 months (odds ratio
.284; 95% confidence interval [CI] 0.100 to 0.812, p 
.034). The Kaplan-Meier actuarial estimates of AF recur-
ence after 3, 6, and 18 months were 12.8%, 15.4%, and
5.4% in the biatrial ablation group and 24.4%, 34.1%, and
atomic reconstruction of the right and the left atrium. Multiple dark red
trium: (A) the isthmus line between the tricuspid annulus and the inferior
the superior vena cava, proceeds to the fossa ovalis, and to the coronary
inferior vena cava. In the left atrium, a circumferential lesion was placedctroan
ight a
s from
n theg the left circular lesion with the mitral annulus was placed (D). LAO 
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Left and Right Atrial Ablation in Atrial Fibrillation June 20, 2006:2504–129% in the left atrial ablation group (log-rank p  0.022)
Fig. 3).
After six months of follow-up, 21 of 41 in the left atrial
roup, and 18 of 39 patients in the biatrial group were
ontinued on antiarrhythmic drugs after the initial six
onths and for the remainder of follow-up. In the interval
etween six months and the end of follow-up, 23 of the 80
atients (7 in the left atrial and 16 in the biatrial group) were
F free without antiarrhythmic therapy. Figure 4 shows the
uccess rates with and without antiarrhythmic drugs in the
wo groups. Table 2 shows the effect of antiarrhythmic
rugs in patients with persistent and permanent AF who
nderwent biatrial and left atrial ablation. Twenty-one of
he 22 patients with AF recurrence were on antiarrhythmic
rug therapy.
In the multivariate Cox regression analysis, after adjust-
ent for age, gender, left atrial dimensions, structural heart
isease, type of AF (persistent vs. permanent), and contin-
ation of antiarrhythmic therapy after six months from the
blation procedure, the ablation technique (biatrial ablation)
as found to be an independent negative predictor of AF
ecurrence (hazard ratio of 0.223, 95% CI 0.80 to 0.623,
 0.004). Moreover, a left ventricular ejection fraction
45% was found to be an independent positive predictor of
F recurrence (hazard ratio of 5.162, 95% CI 2.009 to
3.262, p  0.001).
omplications. Two major complications were observed
oon after the procedure: a retroperitoneal hematoma and
igure 2. Examples of termination of atrial fibrillation during radiofrequen
oth patients had failure of electric cardioversion. Note that the atrial fibri
ine) after progressive prolongation of cycle length of FF intervals. ABL D
inus; DCS  distal coronary sinus; PCS  proximal coronary sinus; RVn hemothorax (both patients were in the left atrial ablation Sroup). Six patients (four in the biatrial ablation group)
eveloped atypical atrial flutter in the first three weeks after
blation. Additional ablation was not required in these
atients because the arrhythmia was spontaneously self-
erminating during the six-week blanking period.
ISCUSSION
ain findings. In this study, conducted in 80 symptomatic
atients with either persistent and permanent AF, most
ith structural heart disease, the following were observed: 1)
iatrial ablation was superior to left atrial ablation in
aintaining patients free of AF recurrence during 14  5
onths (15% vs. 39% of AF recurrence); 2) the total
rocedure time was increased by the biatrial ablation of 1
in comparison with left atrial ablation; 3) complications
ere rare and uniformly present in the two arms of our
tudy; and 4) the ablation technique and the ejection
raction were found by multivariate analysis to be indepen-
ent predictor of AF recurrence.
revious studies. Few and conflicting data have been
eported about the effects of catheter ablation in persistent
nd permanent AF (1,26,29,30). Swartz et al. (29) had a
uccess rate up to 90%, but a 22% incidence of major
omplications, by performing biatrial linear lesions in pa-
ients with chronic AF. Additional studies operating a
ompartmentalization of the right atrium and/or left atrium
enerally showed a low success rate in chronic AF (31,32).
F) application in two patients (A and B) with permanent atrial fibrillation.
n termination occurred in both patients during right atrial ablation (septal
tal ablation catheter; ABL P  proximal ablation catheter; CS  coronary
right ventricular apex.cy (R
llatioubsequently, several studies pointed to the importance of
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June 20, 2006:2504–12 Left and Right Atrial Ablation in Atrial Fibrillationhe PVs as a critical area for the initiation and maintenance
f AF (1,4,33). Haïssaguerre et al. (30) showed 60%
ong-term success after PV isolation in patients with chronic
F. On the contrary, Oral et al. (1) reported that persistent
F usually is not eliminated by PV disconnection (22% of
atients AF free). This finding is consistent with two
urgical studies in which PV isolation maintained sinus
hythm in 33% (34) and 20% of patients (35). Recently, Hsu
t al. (2) demonstrated a higher success rate (70% to 80%) in
atients with persistent and permanent AF by the addition
f left atrial ablation lines and cavotricuspid isthmus abla-
ion to PV disconnection, and using the prevention of AF
nducibility as other target of the ablative procedure (28),
ven if a repeated ablation was necessary in approximately
0% of patients. A different kind of approach (26), in which
he complex fractionated electrograms recorded during AF
n both atria were the target sites for catheter ablation,
btained stable sinus rhythm in 70% of patients with
hronic AF at one-year follow-up after a single ablative
ession. The antral or circumferential ablation of PV was
eported to be effective in approximately 70% of patients
ith chronic AF (4,5). In the present study, the success rate
f PV encircling combined with the left isthmus and the
avotricuspid isthmus ablation was lower. However, results
imilar to ours have been reported by other studies (6,8,36).
igure 3. Voltage maps of the right (A) and left atrium (B) before ablation
oltage and blue and purple, highest voltage. Multiple dark red dots represe
lectrograms recorded from distal electrode pairs (upper tracing) and pro
he right and left atrium are also shown.rnst et al. (8) had a success of 58% in patients mostly with daroxysmal AF. Karch et al. (36) observed in drug-resistant
F (43 paroxysmal and 7 persistent AF) after PV encircling
success rate at six months of 42% using seven-day Holter
onitoring and 54% basing on arrhythmia-related symp-
oms. Kottkamp et al. (6), after circular plus linear left atrial
esions in persistent AF, showed freedom from AF in 38%
f patients evaluated with 24-h Holter monitoring and 22%
ith seven-day ECG.
In our study, the prevalence of atypical atrial flutter (7%
cute, 0% long term) was lower than other studies (6,7). It
an be hypothesized that, in our patients, both the addi-
ional lesions in the right atrium and the use of antiarrhyth-
ic drugs for at least six months have reduced the incidence
f atypical atrial flutter and favored its spontaneous termi-
ation. Also, it is possible that in other studies the creation
f several linear lesions in the left atrium (such as roof and
osterior lines), often incomplete, more frequently led to
ap-related atrial flutter.
otential mechanisms of the efficacy of the combined left
nd right atrial ablation. A significant difference in the
lectrical activity was found between patients with chronic
nd paroxysmal AF (9,10). Lazar et al. (9) demonstrated
hat a left-to-right atrial frequency gradient exists for
aroxysmal but not for persistent AF and postulated that
he maintenance of persistent or chronic AF may be less
and after ablation (bottom) (posteroanterior view). Red represents lowest
lation lines. Pink dots represent area of complex fractionated electrograms.
electrode pairs (bottom tracing) of ablation catheter in different areas of(top)
nt abependent on posterior left atrium. Recently, Sanders et al.
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Left and Right Atrial Ablation in Atrial Fibrillation June 20, 2006:2504–1237) observed that in patients with paroxysmal AF domi-
ant sources of activity are often localized to the PVs, and,
n contrast in patients with permanent AF, these dominant
requency sites are more often localized to the atria, includ-
ng right atrial sites (37).
Combined left and right atrial linear ablation has been
hown to eliminate chronic AF in animal models (11–15)
nd, specifically, two experimental studies demonstrated
hat biatrial ablation is more effective than right and left
able 2. Success Rates With and Without Antiarrhythmic
rugs in Patients With Persistent and Permanent Atrial
ibrillation Who Underwent Biatrial and Left Atrial Ablation
Biatrial
Ablation
(n  39)
Left Atrial
Ablation
(n  41)
p
Value
ersistent atrial fibrillation, n 19/39 (49%) 24/41 (59%) 0.4
Unsuccessful, n 2/19 (11%) 8/24 (33%) 0.2
Successful without drugs, n 9/19 (47%) 5/24 (21%) 0.1
Successful with drugs, n 8/19 (42%) 11/24 (46%) 0.9
Amiodarone, n 2/8 (25%) 4/11 (36%) 0.7
Sotalol, n 2/8 (25%) 3/11 (28%) 0.9
Class 1C, n 4/8 (50%) 4/11 (36%) 0.8
ermanent atrial fibrillation, n 20/39 (51%) 17/41 (41%) 0.4
Unsuccessful, n 4/20 (20%) 8/17 (47%) 0.3
Successful without drugs, n 7/20 (35%) 2/17 (12%) 0.1
Successful with drugs, n 9/20 (45%) 7/17 (41%) 0.4
Amiodarone, n 4/9 (45%) 3/7 (42%) 0.9
Sotalol, n 2/9 (22%) 2/7 (29%) 0.6
Figure 4. Kaplan-Meier estimate of survival free of atrial fibrillationrClass 1C, n 3/9 (33%) 2/7 (29%) 0.9trial ablation alone to cure chronic AF (14,15). In humans,
he Maze procedure, characterized by lesions in both atria,
as effective in maintaining sinus rhythm in 99% of patients
ith chronic AF (38). Subsequently, surgical studies showed
hat lesions confined to the posterior part of the left atrium
ere effective, but with a lower percentage of success, in
liminating AF (34,35,39).
In our experience, a specific right atrial linear concept was
ffective with antiarrhythmic drugs in 66% of patients with
efractory AF (25). The rationale for our approach in the
ight atrium was to create lesions in areas that seem to be
ritical in the maintenance and/or the induction of AF. In
act, the posterior and the septal wall have shown conduc-
ion deterioration, increased non-uniform anisotropy, and
isorganized electrical activity (10,16,17,20,26). The septal
ine performed at the level of the interatrial connections
ave been shown to be highly effective in experimental
tudies (18,19,40). In humans, the CS was found to be a
ource of rapid repetitive electrical activity, and the electrical
isconnection of the CS from the left atrium reduced the
nducibility of sustained AF (41). In patients with AF and
heumatic heart disease, the ablation performed near the CS
stium was effective in 70% of cases (21). Also, Cox et al.
38) considered the cryoablation of CS as one of the most
mportant steps in the surgical therapy of AF. Moreover, the
ight atrium is rarely the source of AF (22,23). Natale et al.
22) reported that 37.5% of chronic AF patients had
ight-sided foci. Furthermore, right atrial re-entrant ar-
r biatrial ablation (solid line) and left atrial ablation (dotted line).hythmias determining AF have been reported, and short
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June 20, 2006:2504–12 Left and Right Atrial Ablation in Atrial Fibrillationines of ablation lesion were effective in the cure of AF in
hese cases (24). Finally, the linear lesions performed in
he posterior wall, inside the superior vena cava, and
ehind the CS ostium, other than in the posterior wall of
he left atrium, could affect vagal enervation. In fact, these
reas contain the largest populations of cardiac ganglia (42),
nd ablation of atrial parasympathetic nerve system demon-
trated the abolishment of vagally mediated AF in dogs
43).
Furthermore, the success of the procedure can be, at least
n part, related to the elimination of critical areas of slow
onduction and/or pivot points by the ablation of complex
ractionated electrograms found in both right and left
trium (7,26).
tudy limitations. This study has some limitations. The
rst limitation is that asymptomatic paroxysmal AF may
ave recurred in some patients. In fact, the clinical efficacy
as based on symptoms and on ambulatory monitoring
erformed every three months. However, considering that
he study is randomized, the eventual asymptomatic recur-
ences could be expected to be equally distributed in both
roups. Another limitation is that none of the patients with
elapse of AF was submitted to a second ablation procedure.
herefore, we are not able to determine the possible reasons
or AF recurrences in these patients and to assess the
otential increase of the success rate after a second proce-
ure. Moreover, it is quite possible that recurrence rate
ould have been higher in both groups had drug therapy
een stopped in all patients at six months. Furthermore,
any of our patients continued antiarrhythmic drugs (in-
luding amiodarone). This should be considered, when the
atient desires AF catheter ablation to stop antiarrhythmic
rugs. An additional potential limitation is that the efficacy
f left-sided ablation alone may have been enhanced by
sing electrophysiologic end points such as elimination of
V potentials and demonstration of lines of block. Finally,
omplete PV isolation probably can further reduce the
ncidence of atypical atrial flutter (44).
onclusions. This study first demonstrates that, in pa-
ients with persistent and permanent AF, the addition of
ultiple linear lesions in the right atrium to circumferential
V ablation determines a significant higher success rate
han circumferential PV and cavotricuspid isthmus ablation
lone. The biatrial approach showed to be feasible, safe, and
ffective in modifying the right and left AF substrate. The
ombination of right atrial linear lesions with the PV
ncircling can avoid the need of additional lines in the left
trium, which are technically challenging, potentially proar-
hythmic, increase the risk of serious complications, and
ay impair the left atrial contractility.
If these preliminary data will be confirmed in randomized
rials with larger population and longer follow-up, in pa-
ients with a prevalent substrate-mediated AF, the biatrial
pproach could be the treatment of choice.eprint requests and correspondence: Dr. Leonardo Calò, Di-
ision of Cardiology, Policlinico Casilino, Via Buonarroti, 16,
0047 Marino, Rome, Italy. E-mail: leonardo.calo@tin.it.
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